Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mosaic ImmunoEngineering Inc. (CPMV : OTC)

• Company Description    Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. It is focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. The company's product pipeline includes MI-O-101. Mosaic ImmunoEngineering Inc., formerly known as Patriot Scientific Corporation, is based in NOVATO, CA. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $0.40 Daily Weekly Monthly 20 Day Moving Average: 466 shares Shares Outstanding: 7.24 (millions) Market Capitalization: $2.91 (millions) Beta: -1.20 52 Week High: $1.00 52 Week Low: $0.25 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.53% -15.05% 12 Week 22.37% 11.15% Year To Date -42.65% -48.80%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9114 ADAMS AVENUE SUITE 202 - HUNTINGTON BEACH,CA 94646 USA ph: 657-208-0890 fax: 760-547-2705 info@mosaicie.com http://www.mosaicie.com

• General Corporate Information    Officers Steven King - Chief Executive Officer; President and Director Paul Lytle - Chief Financial Officer; Director Robert Baffi - Director Robert Garnick - Director Robert Garnick - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 61945M101 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/18/25 Share - Related Items Shares Outstanding: 7.24 Most Recent Split Date: 12.00 (0.00:1) Beta: -1.20 Market Capitalization: $2.91 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/18/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 50.00% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -822.45 03/31/25 - -1,117.89 12/31/24 - -1,351.96 Current Ratio 06/30/25 - 0.01 03/31/25 - 0.02 12/31/24 - 0.03 Quick Ratio 06/30/25 - 0.01 03/31/25 - 0.02 12/31/24 - 0.03 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - -0.99 03/31/25 - -0.96 12/31/24 - -0.94 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©